The Board Certified Medical Affairs Specialist (BCMAS) program has become a cornerstone of the medical affairs and MSL profession. However, some critics question the necessity of certification for MSLs and Medical Affairs Professionals. Let’s address these concerns and explore the true value of BCMAS certification.
One criticism centers on the idea that experience trumps certification. While experience is undoubtedly valuable, the healthcare landscape is constantly evolving. BCMAS ensures a deep understanding of core competencies across various medical affairs functions, from regulatory affairs to health economics. This comprehensive knowledge empowers professionals to adapt to changing regulations and scientific advancements.
Another concern is the cost and time commitment associated with BCMAS. While true, the return on investment is significant. Certification demonstrates a dedication to professional development, setting you apart from non-certified peers. This can translate to career advancement opportunities and potentially higher earning potential. BCMAS professionals are placed in the ACMA database where they can be connected to MSL and Medical affairs recruiters as well as being invited into a private LinkedIn group which has industry leaders. All of this can be a tremendous help with networking which can significantly increase the chances of landing a role. The ACMA offers free mentorship to those enrolled in the BCMAS program. Mentors come from the pharmaceutical industry and can help those without previous MSL or medical Affairs experience tremendously.
Perhaps the most significant criticism revolves around potential industry bias. However, the BCMAS program is overseen by the Accreditation Council for Medical Affairs (ACMA), an independent body. The curriculum emphasizes ethical practices and ensures medical science liaisons (MSLs) prioritize patient well-being over commercial goals. BCMAS certification fosters trust and transparency within the pharmaceutical industry, addressing past concerns about promotional tactics.
Additionally, the results that BCMAS has demonstrated are backed by research. Studies have shown an 80% increase in knowledge (p value < 0.001) among learners who completed ACMA educational programs. Furthermore, a study published by Pharmacy Times demonstrated a significantly higher average salary for Medical Affairs and MSL professionals who complete the BCMAS program.
Moreover, BCMAS can help to mitigate compliance and risk issues for pharmaceutical and biotech companies by ensuring that all MSL and medical affairs professionals have a uniform level of knowledge and meet minimum competency standards.
BCMAS has been around since 2015 and is backed by the Accreditation Council for Medical Affairs and is also accredited by the International Accreditors for Continuing Education and Training (IACET /ANSI). Additionally, US licensed physicians and pharmacists can earn CME /CE credits which are accredtied by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE). No other MSL and Medical affairs certification program offers this level of rigor.
Today, BCMAS is the largest and most well recognized standard for Medical Affairs and MSL professionals worldwide. BCMAS professionals come from over 80+ countries. Moreover the ACMA works with over 250+ pharmaceutical, biotech, diagnostic and medical device organizations around the world.
Ultimately, BCMAS certification is not just a badge; it’s a symbol of expertise, commitment, and ethical conduct for Medical Affairs and MSL professionals. In a field where scientific accuracy and trust are paramount, BCMAS certification elevates the medical affairs profession, ensuring MSLs can effectively bridge the gap between scientific advancements and best practices in patient care.